Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Birth Control Methods01:22

Birth Control Methods

5.8K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
5.8K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

192
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
192
Menses Phase01:18

Menses Phase

1.0K
The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
1.0K
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

1.3K
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.3K
The Menstrual Cycle01:19

The Menstrual Cycle

3.1K
The menstrual cycle is a recurrent sequence of changes in the uterine endometrium, specifically its functional layer, the stratum functionalis. This cycle prepares the uterus for potential pregnancy. This cycle typically spans 21–35 days, averaging 28 days, and aligns with the ovarian cycle, regulated by fluctuating levels of ovarian hormones, primarily estrogen and progesterone.
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Impact of estroprogestin therapies on bone health from adolescence to postmenopause.

Journal of endocrinological investigation·2026
Same author

Perimenopausal hot flashes do not depend on crude circulating oestradiol levels: further evidences from women treated with oral GnRH antagonists combination therapy for symptomatic fibroids.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
Same author

Impact of estroprogestin therapies on bone health from adolescence to postmenopause.

Journal of endocrinological investigation·2026
Same author

Is the contraindication to combined hormonal contraceptive use in asymptomatic women carrying mild thrombophilia still justified?

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
Same author

Hormonal contraception and breast cancer: the impact of formulation era, age, and ethnicity.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2025
Same author

One-year clinical experience on the thromboembolic safety profile of the first prolonged release combined oral contraceptive containing 2 mg dienogest and 0.02 mg ethinyl-oestradiol.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2025

Related Experiment Video

Updated: Jan 14, 2026

Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri
05:21

Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri

Published on: September 12, 2025

385

Understanding Problematic Bleeding When Using Contraception: Guidance for Clinicians.

Marta Barretta1, Giovanni Grandi2

  • 1Department of Obstetrics and Gynecology, Ramazzini Hospital, Carpi (MO), 41012, Italy.

Open Access Journal of Contraception
|October 20, 2025
PubMed
Summary
This summary is machine-generated.

Abnormal uterine bleeding (AUB) is a frequent side effect of hormonal contraceptives (HCs). This framework helps clinicians manage AUB by improving counseling and individualizing contraceptive choices for better adherence.

Keywords:
abnormal uterine bleedingbreakthrough bleedingcombined oral contraceptiveshormonal contraceptionprogestin-only contraceptionwithdrawal bleeding

More Related Videos

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

647
OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery
05:31

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

4.6K

Related Experiment Videos

Last Updated: Jan 14, 2026

Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri
05:21

Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri

Published on: September 12, 2025

385
A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

647
OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery
05:31

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

4.6K

Area of Science:

  • Reproductive Endocrinology
  • Gynecology
  • Contraception

Background:

  • Abnormal uterine bleeding (AUB) is a common adverse effect of hormonal contraceptive (HC) use.
  • AUB significantly contributes to treatment discontinuation among users of hormonal contraception.
  • Understanding AUB is crucial for improving patient adherence and satisfaction with contraceptive methods.

Purpose of the Study:

  • To present a structured clinical framework for managing abnormal uterine bleeding (AUB) in patients using hormonal contraceptives (HCs).
  • To emphasize the role of patient counseling and individualized contraceptive selection in addressing AUB.
  • To provide clinicians with a practical tool for managing this prevalent issue.

Main Methods:

  • Review and synthesis of current literature on AUB associated with hormonal contraception.
  • Development of a clinical management framework based on established principles.
  • Identification of strategies to improve patient adherence and address bleeding patterns.

Main Results:

  • Hormonal contraceptives (HCs), including combined oral contraceptives (COCs) and progestin-only contraception (POC), can cause different types of abnormal uterine bleeding (AUB).
  • Breakthrough bleeding (BTB) in COCs may result from hormonal fluctuations, while POC is linked to endometrial changes.
  • Non-compliance is a significant factor contributing to unscheduled bleeding.

Conclusions:

  • Effective management of AUB in HC users requires appropriate counseling and individualized contraceptive choices.
  • A structured approach can help clinicians navigate the complexities of AUB management.
  • Addressing AUB is essential for improving treatment adherence and patient outcomes in contraception.